Cargando…

Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma

BACKGROUND: RNASET2 has been identified as an oncogene with anti-angiogenic and immunomodulatory effects in a variety of cancers, but its function in clear cell renal cell carcinoma (ccRCC) is still not well understood. METHODS: The RNASET2 expression matrix was extracted from the The Cancer Genome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yifu, Zhang, Zhicheng, Xi, Ping, Chen, Ru, Cheng, Xiaofeng, Liu, Ji, Zhu, Qiqi, Nie, Yechen, Sun, Ting, Gong, Binbin, Wang, Siyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483861/ https://www.ncbi.nlm.nih.gov/pubmed/37679715 http://dx.doi.org/10.1186/s12885-023-11356-6

Ejemplares similares

Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma
por: Liu, Yifu, et al.
Publicado: (2023)

Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma
por: Fu, Shengqiang, et al.
Publicado: (2021)

A comprehensive analysis of the prognostic value and immune infiltration of low expression DBT in clear cell renal cell carcinoma
por: Xie, Wenjie, et al.
Publicado: (2022)

Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma
por: Liu, Yifu, et al.
Publicado: (2021)

GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment
por: Liu, Yifu, et al.
Publicado: (2022)

HIF2α‐induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma
por: Quan, Yanmei, et al.
Publicado: (2023)

Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer
por: Zhou, Libo, et al.
Publicado: (2023)

Novel amino acid metabolism‐related gene signature to predict prognosis in clear cell renal cell carcinoma
por: Cheng, Xiaofeng, et al.
Publicado: (2022)

Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma
por: Fu, Shengqiang, et al.
Publicado: (2022)

Prognostic and immunological significance of calcium-related gene signatures in renal clear cell carcinoma
por: Liu, An, et al.
Publicado: (2022)

Chromosome 6 encoded RNaseT2 protein is a cell growth regulator
por: Liu, Jinglan, et al.
Publicado: (2010)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

Systematic pan-cancer analysis identifies gasdermin B as an immunological and prognostic biomarker for kidney renal clear cell carcinoma
por: Liu, Xuehe, et al.
Publicado: (2023)

The prognostic value and immunological role of the small mother against decapentaplegic proteins in kidney renal clear cell carcinoma
por: Zhang, Siyue, et al.
Publicado: (2021)

The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma
por: Chu, Binxiang, et al.
Publicado: (2022)

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Gong, Yun, et al.
Publicado: (2022)

Mammalian mitochondrial RNAs are degraded in the mitochondrial intermembrane space by RNASET2
por: Liu, Peipei, et al.
Publicado: (2017)

Systematic Chromatin Accessibility Analysis Based on Different Immunological Subtypes of Clear Cell Renal Cell Carcinoma
por: Zhang, Shiqiang, et al.
Publicado: (2021)

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Wu, Yue, et al.
Publicado: (2021)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2019)

Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells
por: Acquati, Francesco, et al.
Publicado: (2011)

Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase
por: Lualdi, Marta, et al.
Publicado: (2015)

The failure of microglia to digest developmental apoptotic cells contributes to the pathology of RNASET2‐deficient leukoencephalopathy
por: Hamilton, Noémie, et al.
Publicado: (2020)

A comprehensive prognostic and immunological analysis of telomere-related lncRNAs in kidney renal clear cell carcinoma
por: Chen, Ji, et al.
Publicado: (2023)

Regulation of mitochondrion-associated cytosolic ribosomes by mammalian mitochondrial ribonuclease T2 (RNASET2)
por: Huang, Jinliang, et al.
Publicado: (2018)

Human recombinant RNASET2: A potential anti-cancer drug
por: Roiz, Levava, et al.
Publicado: (2016)

RNaseT2 knockout rats exhibit hippocampal neuropathology and deficits in memory
por: Sinkevicius, Kerstin W., et al.
Publicado: (2018)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

Integrative Analysis of Sirtuins and Their Prognostic Significance in Clear Cell Renal Cell Carcinoma
por: Tan, Ying, et al.
Publicado: (2020)

Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

Prognostic value of peripheral blood T lymphocyte subsets in clear cell renal cell carcinoma
por: Zhou, Yihong, et al.
Publicado: (2021)

Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer
por: Ji, Mei, et al.
Publicado: (2021)

Prognostic Value of an m(5)C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell Carcinoma
por: Li, Hanrong, et al.
Publicado: (2021)

A Cell-Autonomous Oncosuppressive Role of Human RNASET2 Affecting ECM-Mediated Oncogenic Signaling
por: Roggiani, Francesca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5ssc8kc60kiampo2vikvddqjdb